Drug – bio-affecting and body treating compositions – Live hair or scalp treating compositions
Reexamination Certificate
1998-02-24
2001-06-19
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Live hair or scalp treating compositions
C424S070110, C424S070130, C424S070150
Reexamination Certificate
active
06248313
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to hair-cosmetic formulations with improved film-forming properties containing cationic biopolymers and polyvinyl pyrrolidone/vinyl acetate copolymers in selected mixing ratios and to the use of the cationic biopolymers for improving the film-forming properties of the said copolymers.
1. Prior Art
Hair-cosmetic formulations, for example lacquers or styling preparations, set through the presence of polymers, preferably of the polyvinyl pyrrolidone/vinyl acetate type, which are absorbed by the keratin fibers and provide them with the required hold. However, the disadvantage of these polymers is that, after repeated application, the films become brittle on drying so that not only is the styling effect lost, the hair can also be damaged.
Accordingly, the problem addressed by the present invention was to provide cosmetic formulations which, although containing polyvinyl pyrrolidone/vinyl acetate copolymers as film formers, would have a significantly reduced tendency towards stress cracking for at least the same film hardness.
2. Description of the Invention
The present invention relates to hair-cosmetic formulations containing
a) cationic biopolymers and
b) polyvinyl pyrrolidone/vinyl acetate copolymers in a ratio by weight of 1:5 to 1:50.
It has surprisingly been found that the addition of even very small quantities of cationic biopolymers to polyvinyl pyrrolidone/vinyl acetate copolymers, whose film-forming properties are individually known, has a moisture-regulating effect and synergistically reduces the tendency towards stress cracking without any adverse effect on film hardness. In view of the fact that the cationic biopolymers are very costly to produce and are therefore expensive, the possibility of significantly improving the performance properties of the copolymers by adding very small quantities also represents a particular economic advantage.
Cationic biopolymers
According to the invention, particularly suitable cationic biopolymers for component a) are hydrocolloids of the chitosan type. Chemically, they are partly deacetylated chitins varying in molecular weight which contain the idealized monomer unit (I):
In contrast to most hydrocolloids, which are negatively charged at biological pH values, chitosans are cationic biopolymers under these conditions. The positively charged chitosans are capable of interacting with oppositely charged surfaces and, accordingly, are used in cosmetic hair-care and body-care formulations, for example as film formers. Besides chitosans, quaternized, alkylated and/or hydroxyalkylated derivatives, optionally in microcrystalline form, may also be used. The chitosans and their derivatives are generally used in the form of aqueous gels with a solids content of 1 to 5% by weight.
Reviews on this subject have been published, for example, by B. Gesslein et al. in HAPPI 27, 57 (1990), by O. Skaugrud in Drug Cosm. Ind. 148, 24 (1991) and by E. Onsoyen et al. in Seifen-Öle-Fette-Wachse 117, 633 (1991).
Chitosans are produced from chitin, preferably from the shell remains of crustaceans which are available in large quantities as inexpensive raw materials. Normally, the chitin is first deproteinized by addition of bases, demineralized by addition of mineral acids and, finally, deacetylated by addition of strong bases, the molecular weights being spread over a broad range. Corresponding processes for the production of—microcrystalline-chitosan are described, for example, in WO 91/05808 (Firextra Oy) and in EP-B1 0 382 150 (Hoechst).
One preferred embodiment of the invention is characterized by the use of particularly low-ash cationic biopolymers which are obtained by
(a) treating fresh crustacean shells with dilute aqueous mineral acid,
(b) treating the resulting demineralized first intermediate product with aqueous alkali metal hydroxide solution,
(c) treating the resulting lightly deproteinized second intermediate product with more dilute aqueous mineral acid,
(d) finally treating the resulting decalcified third intermediate product with concentrated aqueous alkali metal hydroxide and deacetylating it to a content of 0.05 to 0.5 and, more particularly, 0.15 to 0.25 mole acetamide per mole monomer unit and
(e) optionally carrying out a pressure/heat aftertreatment to adjust the viscosity.
Polyvinyl pyrrolidone/vinyl acetate copolymers
Polyvinyl pyrrolidone/vinyl acetate copolymers (PVP/VA), which form component b), represent known protective colloids for cosmetic applications which are marketed, for example, under the name of Luviskol® by BASF AG of Ludwigshafen. FRG. The copolymers are normally used in the form of aqueous solutions with a solids content of 1.5 to 30% by weight. The formulations may contain components a) and b) in a ratio by weight (based on dry matter) of 1:5 to 1:50, preferably 1:10 to 1:45 and more preferably 1:30 to 1:40.
Commercial Applications
Mixtures of cationic biopolymers and polyvinyl pyrrolidone/vinyl acetate copolymers show improved film-forming properties. Accordingly, the present invention also relates to the use of cationic biopolymers as additives for improving the film-forming properties of polyvinyl pyrrolidone/vinyl acetate copolymers.
Hair-cosmetic formulations
The formulations according to the invention may contain surfactants, emulsifiers, superfatting agents, thickeners, cationic polymers, silicone compounds, biogenic agents, film formers, preservatives, dyes and perfumes as further auxiliaries and additives.
Typical examples of suitable surfactants are fatty alcohol polyglycol ether sulfates, monoglyceride sulfates, mono- and/or dialkyl sulfosuccinates, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides, ether carboxylic acids, alkyl oligoglucosides, fatty acid glucamides, alkylamido-betaines and/or vegetable protein fatty acid condensates.
Suitable emulsifies are both known w/o and o/w emulsifiers such as, for example, hydrogenated and ethoxylated castor oil, polyglycerol fatty acid esters or polyglycerol polyricinoleates or polyglycerol poly-12-hydroxystearates.
Superfatting agents may be selected from such substances as, for example, polyethoxylated lanolin derivatives, lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides, the fatty acid alkanolamides also serving as foam stabilizers.
Suitable thickeners are, for example, polysaccharides, more particularly xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose; relatively high molecular weight polyethylene glycol monoesters and diesters of fatty acids, polyacrylates, polyvinyl alcohol and polyvinyl pyrrolidone; surfactants such as, for example, narrow-range fatty alcohol ethoxylates or alkyl oligoglucosides; and electrolytes, such as sodium chloride and ammonium chloride.
Suitable cationic polymers are, for example, cationic cellulose derivatives, cationic starch, copolymers of diallyl ammonium salts and acrylamides, quaternized vinyl pyrrolidone/vinyl imidazole polymers such as, for example, Luviquat® (BASF AG, Ludwigshafen, FRG), condensation products of polyglycols and amines, quaternized collagen polypeptides such as, for example, Lauryidimonium Hydroxypropyl Hydrolyzed Collagen (Lamequat®L, Grünau GmbH), polyethyleneimine, cationic silicone polymers such as, for example, Amidomethicone or Dow Corning 929, Dow Corning Co., USA, copolymers of adipic acid and dimethylaminohydroxypropyl diethylenetriamine (Cartaretine®, Sandoz AG, CH), polyaminopolyamides as described, for example, in FR-A 2 252 840 and crosslinked water-soluble polymers thereof, cationic chitin derivatives such as, for example, quaternized chitosan, optionally in microcrystalline distribution, cationic guar gum such as, for example, Jaguar®CBS, Jaguar®C-17, Jaguar®C-16 of Celanese, USA, quaternized ammonium salt polymers such as, for example, Mirapol® A-15, Mirapol® AD-1, Mirapol® AZ-1 of Miranol, USA.
Suitable silicone compounds are, for example, dimethyl polysiloxanes, methylphenyl polysiloxanes, cyclic silicones and amino-, fatty
Heyer Michael
Hofmann Matthias
Kahre Joerg
Wachter Rolf
Drach John E.
Henkel Kommanditgesellschaft auf Aktien
Murphy Glenn E.
Page Thurman K.
Tran S.
LandOfFree
Hair cosmetic preparations containing cationic biopolymers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hair cosmetic preparations containing cationic biopolymers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hair cosmetic preparations containing cationic biopolymers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2462138